Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
19 hedge funds and large institutions have $1.15M invested in Coeptis Therapeutics Warrants in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
10% less funds holding
Funds holding: 21 → 19 (-2)
54% less capital invested
Capital invested by funds: $2.46M → $1.15M (-$1.32M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$10.4K |
| 2 |
VF
Virtu Financial
New York
|
+$417 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$7K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$20 |
| 4 |
Walleye Capital
New York
|
-$16 |
COEPW Hedge Fund Activity: Q1 2022 in Review
19 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2022, worth a combined $1.15M — down 54% from $2.46M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of COEPW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was AQR Arbitrage, adding an estimated $10.4K. The largest seller was CSS LLC, exiting entirely with an estimated $7K sold.
- 19 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2022, down from 21 in Q4 2021.
- Funds reported $1.15M of Coeptis Therapeutics Warrants stock for Q1 2022, down 54% quarter-over-quarter.
- 0 funds opened new Coeptis Therapeutics Warrants positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q1 2022 was AQR Arbitrage, an estimated $10.4K added.
- The largest Coeptis Therapeutics Warrants seller in Q1 2022 was CSS LLC, an estimated $7K sold.
Based on aggregated 13F filings for Q1 2022.